Clinical trials / NCT02952508
NCT02952508Phase 2Active not recruiting

Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom

Study sponsor: Cellectar Biosciences, Inc. · CLRB

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2026-06-22Estimated
Enrollment · participants120Estimated
Source updated2026-03-18Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Primary completion date changed

− Before

22 Dec 2025

+ After

22 Jun 2026

Check registry source